ABOUT US
Based in New York City, Lexeo is a clinical-stage company dedicated to advancing pioneering science that fundamentally changes how genetic diseases are treated.
By taking aim at the underlying genetic cause of the devastating diseases we target, we seek to create substantial positive impact and reduce the overwhelming burdens placed on individuals receiving treatment, their caregivers, and healthcare systems.
OUR
Vision
To set a new standard in the treatment of genetic diseases with high unmet need, charting the path to patient outcomes once thought out of reach.
OUR Mission
At Lexeo, our mission is to advance transformative medicines for the genetic conditions that demand them. We build from a deep foundation in cardiac science because the heart is so often the driver of unmet need in genetic disease. This foundation gives us the expertise to target disease at its source and the ambition to follow it wherever it leads.
